Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Br J Cancer ; 110(10): 2427-33, 2014 May 13.
Artigo em Inglês | MEDLINE | ID: mdl-24743709

RESUMO

BACKGROUND: Little is known about whether changes in health-related quality of life (HRQoL) scores from baseline during treatment also predict survival, which we aim to investigate in this study. METHODS: We analysed data from 391 advanced non-small-cell lung cancer (NSCLC) patients enrolled in the EORTC 08975 study, which compared palliative chemotherapy regimens. HRQoL was assessed at baseline and after each chemotherapy cycle using the EORTC QLQ-C30 and QLQ-LC13. The prognostic significance of HRQoL scores at baseline and their changes over time was assessed with Cox regression, after adjusting for clinical and socio-demographic variables. RESULTS: After controlling for covariates, every 10-point increase in baseline pain and dysphagia was associated with 11% and 12% increased risk of death with hazard ratios (HRs) of 1.11 and 1.12, respectively. Every 10-point improvement of physical function at baseline (HR=0.93) was associated with 7% lower risk of death. Every 10-point increase in pain (HR=1.08) was associated with 8% increased risk of death at cycle 1. Every 10-point increase in social function (HR=0.91) at cycle 2 was associated with 9% lower risk of death. CONCLUSIONS: Our findings suggest that changes in HRQoL scores from baseline during treatment, as measured on subscales of the EORTC QLQ-C30 and QLQ-LC13, are significant prognostic factors for survival.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/mortalidade , Neoplasias Pulmonares/mortalidade , Qualidade de Vida , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/psicologia , Cisplatino/administração & dosagem , Ensaios Clínicos Fase III como Assunto/estatística & dados numéricos , Transtornos de Deglutição/epidemiologia , Transtornos de Deglutição/etiologia , Desoxicitidina/administração & dosagem , Desoxicitidina/análogos & derivados , Humanos , Relações Interpessoais , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/psicologia , Estudos Multicêntricos como Assunto/estatística & dados numéricos , Náusea/epidemiologia , Náusea/etiologia , Paclitaxel/administração & dosagem , Dor/epidemiologia , Dor/etiologia , Cuidados Paliativos , Prognóstico , Modelos de Riscos Proporcionais , Ensaios Clínicos Controlados Aleatórios como Assunto/estatística & dados numéricos , Risco , Índice de Gravidade de Doença , Inquéritos e Questionários , Análise de Sobrevida , Gencitabina
2.
Ann Oncol ; 24(1): 231-7, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22935549

RESUMO

BACKGROUND: We examined if cancer patients' health-related quality of life (HRQoL) scores on the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 are affected by the specific time point, before or during treatment, at which the questionnaire is completed, and whether this could bias the overall treatment comparison analyses. PATIENTS AND METHODS: A 'completion-time window' variable was created on three closed EORTC randomised control trials in lung (non-small cell lung cancer, NSCLC) and colorectal cancer (CRC) to indicate when the QLQ-30 was completed relative to chemotherapy cycle dates, defined as 'before', 'on' and 'after'. HRQoL mean scores were calculated using a linear mixed model. RESULTS: Statistically significant differences (P<0.05) were observed on 6 and 5 scales for 'on' and 'after' comparisons in the NSCLC and two-group CRC trial, respectively. As for the three-group CRC trial, several statistical differences were observed in the 'before' to 'on' and the 'on' to 'after' comparisons. For all three trials, including the 'completion-time window' variable in the model resulted in a better fit, but no substantial changes in the treatment effects were noted. CONCLUSIONS: We showed that considering the exact timing of completion within specified windows resulted in statistical and potentially clinically significant differences, but it did not alter the conclusions of treatment comparison in these studies.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/fisiopatologia , Neoplasias Colorretais/fisiopatologia , Neoplasias Pulmonares/fisiopatologia , Qualidade de Vida , Carcinoma Pulmonar de Células não Pequenas/terapia , Neoplasias Colorretais/terapia , Humanos , Neoplasias Pulmonares/terapia
3.
J Ultrasound Med ; 6(9): 497-507, 1987 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3669146

RESUMO

To quantitate blood velocity while maintaining the real-time ultrasound image of the intracranial vessels in infants, we used a commercial phased-array pulsed Doppler scanner and developed a transcranial technique to measure the middle cerebral artery velocity, and a fontanellar approach to measure flow velocities in the basilar, internal carotid, anterior cerebral, and the pericallosal arteries. In 22 healthy term and 25 stable preterm infants, the peak spectral systolic velocities in the internal carotid and basilar arteries in term infants were 45 +/- 3.1, and 38.8 +/- 2.5 cm/sec, (mean +/- SEM), respectively. A hierarchical pattern of velocity variation was noted between the large and small intracranial vessels in both the term and preterm infants. The velocities were 30-40% higher in the proximal than in the smaller distal, anterior cerebral, and pericallosal arteries (P less than 0.05). Although the velocities in corresponding vessels were slightly lower in preterm infants than in the term, the differences were statistically not significant. In both groups, the end diastolic velocities did not change significantly among the large and small arteries; therefore, a significant variation in Pourcelot's index (PI, the ratio of maximum systolic-end diastolic difference to the systolic velocity) was noted between the internal carotid and the pericallosal arteries: 0.88 +/- 0.01 vs. 0.76 +/- 0.02, (P less than 0.05). A nearly parabolic velocity profile was documented in the vessels studied.


Assuntos
Artérias Cerebrais/fisiologia , Circulação Cerebrovascular , Recém-Nascido/fisiologia , Recém-Nascido Prematuro/fisiologia , Ultrassom/métodos , Velocidade do Fluxo Sanguíneo , Humanos , Fluxo Sanguíneo Regional
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA